Medication Scheme Implementation Guide
1.0.0 - draft Estonia flag

Medication Scheme Implementation Guide, published by TEHIK. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/TEHIK-EE/ig-ee-medication-scheme/ and changes regularly. See the Directory of published versions

CodeSystem: ER_Asendamatuse põhjus

Official URL: https://fhir.ee/CodeSystem/ravimi-asendamatuse-pohjus Version: 1.0.0
Active as of 2024-10-28 Computable Name: RavimiAsendamatusePohjus
Other Identifiers: OID:1.3.6.1.4.1.28284.6.2.1.281, OID:1.3.6.1.4.1.28284.6.2.1.281.1

Elektrooniline retsept (ER) - Asendamatuse põhjus märgitakse, kui ravim kirjutatakse välja preparaadi nimetuse põhiselt.

This Code system is referenced in the content logical definition of the following value sets:

Generated Narrative: CodeSystem ravimi-asendamatuse-pohjus

Language: et

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
display display http://terminology.hl7.org/CodeSystem/designation-usage|display string Display
Status status http://hl7.org/fhir/concept-properties#status code Status

Concepts

This case-insensitive code system https://fhir.ee/CodeSystem/ravimi-asendamatuse-pohjus defines the following codes:

CodeDisplayStatusEnglish (English, en)
KP01 tegemist on bioloogilise ravimiga active Prohibited since it is a biological medicinal product
KP02 tegemist on kitsa terapeutilise vahemikuga ravimiga active Prohibited since it is a medicinal product with narrow therapeutic index
KP03 patsiendil esineb ülitundlikkus abiaine vastu, mis esineb kõigis teistes sarnastes ja sama toimeainega ravimites active Prohibited because the patient has hypersensitivity for the excipient which is present in all similar medicinal products with same active ingredient
KP04 patsienti on õpetatud kasutama konkreetset manustamisvahendit active Prohibited because the patient has been taught to use this specific means for administration
KP05 patsiendile on paremini talutav konkreetne ravim, mille toimekestus erineb kõigist teistest sama toimeainega ja ravimvormis ravimitest active Prohibited because the patient tolerates this specific medicinal product due to the duration of action, which differs from all other medicinal products with same ingredient and dose form
KP06 tegemist on toiteseguga active Prohibited since it is a nutrition preparation
KP07 abiainete koostis tagab toimeaine sellise vabanemiskoha, mis erineb kõigist teistest sarnastest ja sama toimeainega ravimitest active Prohibited because the content of excipients ensures the site of release for ingredients, which is different from all other similar and with same ingredient medicinal products
KP08 patsiendil on diagnoositud kaasuv psüühika- või käitumishäire active Prohibited because the patient has been diagnosed with concurrent mental or behavioural disorder
KP09 tegemist on müügiloata/erisoodustusega ravimiga active Prohibited since it is a medicinal product with fringe benefit or without market authorization in Estonia